Clinical Trials Logo

Clinical Trial Summary

This is a randomized, multiple doses, crossover clinical study to compare the pharmacokinetic characteristics and the safety between administration of BR9003 and BR9003A in healthy adult subjects. Within each period, randomized subjects will be taken 2 dosing regimens of administrating BR9003 once a day for six days or BR9003A twice a day for six days.


Clinical Trial Description

*Study Objective: After repeated administration of BR9003 2mg and BR9003A 1mg for healthy adult volunteers, the pharmacokinetic properties and safety are evaluated. - Target number of subjects for enrollment (randomization): 24 subjects in total (2 sequence groups(A or B), 12 subjects per sequence group) - Investigational Product 1. Control drug: BR9003A 1mg 2. Test drug: BR9003 2mg - Regimen 1. Control group: Administration of BR9003A 1mg twice a day for six days 2. Test group: Administration of BR9003 2mg once a day for six days ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04857047
Study type Interventional
Source Boryung Pharmaceutical Co., Ltd
Contact Bong-seog Kim
Phone +827088204
Email [email protected]
Status Recruiting
Phase Phase 1
Start date March 31, 2021
Completion date June 2021

See also
  Status Clinical Trial Phase
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Adherence to Anti-Retroviral Therapy (ART) Among People Living With Human Immunodeficiency Virus (HIV) Phase 4
Completed NCT04043728 - Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study N/A
Recruiting NCT04617444 - The ESTxENDS Trial- Effects of Using Electronic Nicotine Delivery Systems (ENDS/Vaporizer/E-cig) on Olfactory Function N/A
Completed NCT03397511 - Incorporating Financial Incentives to Increase Smoking Cessation Among Asian Americans Residing in New York City N/A
Active, not recruiting NCT03931772 - Online Automated Self-Hypnosis Program N/A
Recruiting NCT04133064 - Pivot Breath Sensor Study N/A
Active, not recruiting NCT03187730 - Integrating Financial Management Counseling and Smoking Cessation Counseling to Reduce Health and Economic Disparities in Low-Income Immigrants Phase 4
Completed NCT03474783 - To Explore the Factors Affecting the Effectiveness of Smoking Cessation N/A
Recruiting NCT04635358 - Feasibility Study of Smoking Cessation for the Staff of a Hospital Center N/A
Recruiting NCT03670264 - BE Smokefree: Behavioral Economics Incentives to Engage Adolescents in Smoking Cessation N/A
Recruiting NCT02905656 - Strategies to Promote Cessation in Smokers Who Are Not Ready To Quit N/A
Active, not recruiting NCT02997657 - Positive Psychotherapy for Smoking Cessation Enhanced With Text Messaging: A Randomized Controlled Trial Phase 2
Completed NCT03206619 - A Health Recommeder System to Tailor Message Preferences in a Smoking Cessation Programme
Completed NCT02239770 - Pharmacokinetics of Nicotine Film in Smokers N/A
Completed NCT02562521 - A Smoking Cessation Intervention for Yale Dining Employees Phase 4
Recruiting NCT02422914 - Benefits of Tobacco Free Cigarette N/A
Enrolling by invitation NCT02218944 - Smoking Response Inhibition Training N/A
Completed NCT03002883 - STAND Community College Tobacco Cessation Trial N/A
Completed NCT02230384 - Novel Smoking Cessation Drug for Schizophrenia Phase 2
Completed NCT02246114 - Self-Monitoring of Carbon Monoxide to Enhance Reproductive Outcomes in Women N/A